PT-141 (bremelanotide) is a synthetic peptide that targets melanocortin receptors (primarily MC3R/MC4R). It’s used in preclinical research to investigate central melanocortin signaling, neuroendocrine pathways, and autonomic responses related to arousal, appetite, and cardiovascular regulation.
PT-141 (bremelanotide) is a synthetic peptide that targets melanocortin receptors (primarily MC3R/MC4R). It’s used in preclinical research to investigate central melanocortin signaling, neuroendocrine pathways, and autonomic responses related to arousal, appetite, and cardiovascular regulation.